Phase I study of pre-radiotherapy transcatheter marker placement for pancreatic cancer

Phase I study of pre-radiotherapy transcatheter marker placement for pancreatic cancer - Phase I study of pre-radiotherapy transcatheter marker placement for pancreatic cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008789

Enrollment

Registered

2012-08-29

Start date

2012-08-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Pre-radiotherapy transcatheter marker placement

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Indication for radiotherapy Informed consent

Exclusion criteria

Exclusion criteria: Allergic reaction to contrast agent Short for follow-up period

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Evaluation of inter-fractional movement of the tumor	—

Countries

Japan

Contacts

Public ContactKazuki Terashima

Hyogo Ion Beam Medical Center Department of Radiology

k.terashima@kmyr.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026